KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corporation

Medical Specialities

Industrials

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. It operates in two segments, Domestic and International. The company's products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services. Its laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture; and laminate caseworks that are used in educational, healthcare, and industrial applications. The company sells its products primarily through dealers, commissioned agents, and a national distributor, as well as through competitive bids submitted by the company and its subsidiaries in Singapore, India, and China. Kewaunee Scientific Corporation was founded in 1906 and is headquartered in Statesville, North Carolina.

IPO Year:

Exchange: NASDAQ

Website: kewaunee.com

Recent Analyst Ratings for Kewaunee Scientific Corporation

Date	Price Target	Rating	Analyst

See more ratings

Kewaunee Scientific Corporation

Recent Analyst Ratings for Kewaunee Scientific Corporation

Kewaunee Scientific Corporation

Recent Analyst Ratings for Kewaunee Scientific Corporation

Kewaunee Scientific Corporation Press Releases

Fastest customizable press release news feed in the world

Kewaunee Scientific Announces Amendment to Share Repurchase Program

Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2025

Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2025

Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025

Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2025

Kewaunee Scientific Corporation Completes Acquisition of Nu Aire

Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2025

Kewaunee Scientific Corporation Announces Attendance at the 2024 Arablab Live Tradeshow and Conference

Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2025

Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter

Kewaunee Scientific Corporation SEC Filings

SEC Form SD filed by Kewaunee Scientific Corporation

SEC Form 144 filed by Kewaunee Scientific Corporation

SEC Form 10-Q filed by Kewaunee Scientific Corporation

Kewaunee Scientific Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

Kewaunee Scientific Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

Kewaunee Scientific Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

Amendment: SEC Form SCHEDULE 13D/A filed by Kewaunee Scientific Corporation

Amendment: Kewaunee Scientific Corporation filed SEC Form 8-K: Financial Statements and Exhibits

SEC Form 144 filed by Kewaunee Scientific Corporation

SEC Form 144 filed by Kewaunee Scientific Corporation

Kewaunee Scientific Corporation Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by Kewaunee Scientific Corporation

SEC Form SC 13G/A filed by Kewaunee Scientific Corporation (Amendment)

SEC Form SC 13G/A filed by Kewaunee Scientific Corporation (Amendment)

SEC Form SC 13D/A filed by Kewaunee Scientific Corporation (Amendment)

SEC Form SC 13G/A filed by Kewaunee Scientific Corporation (Amendment)

SEC Form SC 13D/A filed by Kewaunee Scientific Corporation (Amendment)

SEC Form SC 13G/A filed by Kewaunee Scientific Corporation (Amendment)

SEC Form SC 13G/A filed by Kewaunee Scientific Corporation (Amendment)

SEC Form SC 13D filed by Kewaunee Scientific Corporation

SEC Form SC 13G filed by Kewaunee Scientific Corporation

Kewaunee Scientific Corporation Financials

Live finance-specific insights

Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2025

Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025

Kewaunee Scientific Corporation Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Pyle Margaret B was granted 1,896 shares (SEC Form 4)

Director Russell John was granted 1,896 shares, increasing direct ownership by 6% to 34,396 units (SEC Form 4)

Director Gehl Keith M was granted 1,896 shares, increasing direct ownership by 10% to 20,396 units (SEC Form 4)

President, CEO Hull Thomas David Iii sold $59,819 worth of shares (1,844 units at $32.44), decreasing direct ownership by 5% to 36,072 units (SEC Form 4)

Chief Financial Officer Gardner Donald T. Iii sold $148,428 worth of shares (4,000 units at $37.11), decreasing direct ownership by 22% to 14,358 units (SEC Form 4)

Director Gehl Keith M bought $35,000 worth of shares (1,000 units at $35.00), increasing direct ownership by 6% to 18,500 units (SEC Form 4)

Chief Financial Officer Gardner Donald T. Iii sold $120,040 worth of shares (3,000 units at $40.01), decreasing direct ownership by 14% to 18,358 units (SEC Form 4)

Director Gehl Keith M bought $22,500 worth of shares (500 units at $45.00), increasing direct ownership by 3% to 17,500 units (SEC Form 4)

President, CEO Hull Thomas David Iii sold $147,229 worth of shares (3,213 units at $45.82), decreasing direct ownership by 8% to 37,916 units (SEC Form 4)

Director Gehl Keith M bought $19,747 worth of shares (403 units at $49.00), increasing direct ownership by 2% to 17,000 units (SEC Form 4)

Kewaunee Scientific Corporation Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Gehl Keith M bought $35,000 worth of shares (1,000 units at $35.00), increasing direct ownership by 6% to 18,500 units (SEC Form 4)

Director Gehl Keith M bought $22,500 worth of shares (500 units at $45.00), increasing direct ownership by 3% to 17,500 units (SEC Form 4)

Director Gehl Keith M bought $19,747 worth of shares (403 units at $49.00), increasing direct ownership by 2% to 17,000 units (SEC Form 4)

Russell John bought $172,361 worth of shares (7,500 units at $22.98), increasing direct ownership by 30% to 32,500 units (SEC Form 4)